Buchumschlag

СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes

Aim: To determine frequency of tumors with immunohistochemical markers of cancer stem cells (CSC) CD44+/CD24− in patients with breast cancer (BC) of different molecular subtype and to evaluate their prognostic value. Object: Surgical material of 132 patients with BC stage I–II, age from 23 to 75 yea...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Experimental Oncology
Datum:	2015
Hauptverfasser:	Chekhun, S.V., Zadvorny, T.V., Tymovska, Yu.O., Anikusko, M.F., Novak, O.E., Polishchuk, L.Z.
Format:	Artikel
Sprache:	Englisch
Veröffentlicht:	Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2015
Schlagworte:	Original contributions
Online Zugang:	https://nasplib.isofts.kiev.ua/handle/123456789/145447
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Digital Library of Periodicals of National Academy of Sciences of Ukraine
Zitieren:	СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes / S.V. Chekhun, T.V. Zadvorny, Yu.O. Tymovska, M.F. Anikusko, O.E. Novak, L.Z. Polishchuk // Experimental Oncology. — 2015. — Т. 37, № 1. — С. 58-63. — Бібліогр.: 38 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine

Ähnliche Einträge

SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes
von: S. V. Chekhun, et al.
Veröffentlicht: (2015)

Are CD44⁺/CD24⁻ cells the assumed cancer stem cells in breast cancer?
von: Ryspayeva, D.E., et al.
Veröffentlicht: (2017)

Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome
von: Grybach, S.M., et al.
Veröffentlicht: (2018)

The value of iodide symporter for prognosis of breast cancer of different molecular subtypes
von: Yu. Lukianova, et al.
Veröffentlicht: (2017)

Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
von: S. M. Hrybach, et al.
Veröffentlicht: (2018)

Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
von: Lukianova, N.Yu., et al.
Veröffentlicht: (2023)

Clinicopathological features of nonspecific invasive breast cancer according to its molecular subtypes
von: Zavyalova, M., et al.
Veröffentlicht: (2016)

Expression of ITSN2 and TKS5 in different subtypes of breast cancer tumors
von: Kropyvko, S.V., et al.
Veröffentlicht: (2019)

Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
von: Chekhun, S., et al.
Veröffentlicht: (2013)

Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
von: S. Chekhun, et al.
Veröffentlicht: (2013)

EpCAM expression in breast tumor cells and their relation to clinical and pathological parameters and molecular subtype of cancer
von: L. M. Kovalevska, et al.
Veröffentlicht: (2019)

Stem cell therapy for hereditary breast cancer
von: Rassi, H.
Veröffentlicht: (2009)

Predictive and prognostic potential of CD44 and CD24 expression in primary tumour and after chemotherapy in patients with breast cancer
von: D. E. Ryspayeva
Veröffentlicht: (2018)

Research of stem tumor cells subpopulation on models of breast cancer
von: T. S. Herheliuk, et al.
Veröffentlicht: (2022)

Tumor infiltrating lymphocytes and their impact on the effectiveness of the preoperative chemotherapy in various molecular subtypes of locally advanced breast cancer
von: N. O. Verovkina, et al.
Veröffentlicht: (2017)

A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
von: Shepil, O.V., et al.
Veröffentlicht: (2014)

The spectrum of blood serum lipids in patients with breast cancer without metabolic syndrome
von: Timovska, Yu., et al.
Veröffentlicht: (2011)

Orally given chemo-endocrine therapy for patients with luminal Her-2/neu negative metastasing breast cancer
von: Yu. O. Tymovska, et al.
Veröffentlicht: (2016)

Epigenetics in breast cancer
von: Atalay, C.
Veröffentlicht: (2013)

Epigenetics in breast cancer
von: C. Atalay
Veröffentlicht: (2013)

Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
von: Yalovenko, T.M., et al.
Veröffentlicht: (2016)

Features of hepcidin expression in patients with breast cancer
von: Yu. Lukianova, et al.
Veröffentlicht: (2015)

The use of proteomic technologies in breast cancer research
von: Mazur, M.G., et al.
Veröffentlicht: (2016)

Breast cancer with diabetes insipidus
von: Dogan, M., et al.
Veröffentlicht: (2008)

Breast cancer immunohistochemical features in young women with BRCA1/2 mutations
von: Zakhartseva, L.M., et al.
Veröffentlicht: (2009)

Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics
von: Chekhun, V.F., et al.
Veröffentlicht: (2017)

Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
von: Chekhun, V.F., et al.
Veröffentlicht: (2016)

Molecular-genetic bases of clinical heterogeneity of breast cancer (literature review)
von: L. A. Nalieskina, et al.
Veröffentlicht: (2017)

Determination of immunity T-cell link state and content of cancer stem cells as criterion to estimate efficiency of preventive breast cancer therapy with cryopreserved fetal liver cells
von: A. M. Holtsev, et al.
Veröffentlicht: (2014)

Hereditary breast cancer: current state of problem
von: I. M. Motuziuk, et al.
Veröffentlicht: (2018)

Relevance the issues of breast cancer etiology and pathogenesis
von: Ju. A. Vinnik, et al.
Veröffentlicht: (2017)

Staging, risk assessment and screening of breast cancer
von: B. Yalcin
Veröffentlicht: (2013)

Immune checkpoint blockade in breast cancer therapy
von: I. A. Gromakova, et al.
Veröffentlicht: (2020)

The features of reproductive function in women with breast cancer
von: S. E. Ragimzade
Veröffentlicht: (2016)

Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
von: Timovska, Yu.O., et al.
Veröffentlicht: (2009)

Prospects of the use of molecular markers in cancer of ovaries
von: A. A. Mikhanovskij, et al.
Veröffentlicht: (2015)

Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
von: Chekhun, V.F., et al.
Veröffentlicht: (2015)

Fractal dimension of the breast cancer cells resistant and sensitive to doxorubicin activity
von: Medviediev, O., et al.
Veröffentlicht: (2016)

Expression of markers of intercellular adhesion CD44 and CD24 in cells of endometrial carcinoma with high malignancy potential
von: I. P. Nesina, et al.
Veröffentlicht: (2019)

The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer
von: Dumanskiy, Y.V., et al.
Veröffentlicht: (2023)